Patents by Inventor CINDY FEVRE

CINDY FEVRE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHAGE THERAPY
    Publication number: 20240024391
    Abstract: The present invention relates to bacteriophage therapy. More particularly, the present invention relates to novel bacteriophages having a high specificity against Staphylococcus aureus strains, their manufacture, components thereof, compositions comprising the same and the uses thereof in phage therapy and as companion diagnostic.
    Type: Application
    Filed: June 30, 2023
    Publication date: January 25, 2024
    Inventors: CINDY FEVRE, HÉLÈNE BLOIS, MATHIEU MEDINA
  • Anti-bacterial compositions and uses thereof
    Patent number: 11690885
    Abstract: The present invention relates to bacteriophage therapy. More particularly, the present invention relates to novel bacteriophages having a high specificity against Staphylococcus aureus strains, their manufacture, components thereof, compositions comprising the same and the uses thereof in phage therapy and as companion diagnostic.
    Type: Grant
    Filed: March 7, 2018
    Date of Patent: July 4, 2023
    Assignee: PHERECYDES PHARMA
    Inventors: Cindy Fevre, Hélène Blois, Mathieu Medina
  • PHAGE THERAPY
    Publication number: 20200030392
    Abstract: The present invention relates to bacteriophage therapy. More particularly, the present invention relates to novel bacteriophages having a high specificity against Staphylococcus aureus strains, their manufacture, components thereof, compositions comprising the same and the uses thereof in phage therapy and as companion diagnostic.
    Type: Application
    Filed: March 7, 2018
    Publication date: January 30, 2020
    Inventors: CINDY FEVRE, HÉLÈNE BLOIS, MATHIEU MEDINA